Emmanuelle Lepine is mAbxience CEO. She brings to mAbxience over 20 years of experience in the pharmaceutical and biotechnology industry. Emmanuelle is a recognized leader, with hands on experience in establishing and leading successful companies. With her global expertise, Emmanuelle has been supporting organizations to successfully develop, register and launch products on international markets.
Emmanuelle started her career in the pharmaceutical retail sector, to later join the industry in a bioanalytical laboratory at Pharmascience in Canada. During her 12 years at Pharmascience, she was given different leadership roles, first to drive the growth of the International Regulatory Affairs division and later to lead the licensing activities within their global business development unit.
She later spent 5 years with the Alvogen group, where her mandate was to build their biosimilar strategy. Her work led to the creation of Alvotech, where she occupied the position of Deputy CEO. For Alvotech, she supported the company creation, startup activities, business development activities, strategic plan design and execution, as well as being instrumental in supporting all aspects of its first 3 years of growth. In parallel, Emmanuelle was leading her own consultancy company, supporting local and global organizations in the field of Biosimilars.
Emmanuelle holds a Biochemistry degree from University Concordia in Montreal (Canada), as well as a Business degree from the HEC Montreal (Canada) and continued education at Harvard Business School.
“At mAbxience, we create strong value in biopharmaceuticals, and our best endorsement, thousands of patients successfully treated with our products”.
Emmanuelle Lepine, mAbxience CEO.